Public optimism towards nanomedicine

Código QR

Public optimism towards nanomedicine

Massimo Bottini1,2, Nicola Rosato2,3, Fulvia Gloria4, Sara Adanti4, Nunziella Corradino4, Antonio Bergamaschi5, Andrea Magrini41Sanford Burnham Medical Research Institute, La Jolla, CA, USA; 2Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Rome, 3IRCCS-N...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Magrini A, Bergamaschi A, Corradino N, Adanti S, Gloria F, Rosato N, Bottini M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/d6f522d1939d416ca744f159e420f76a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nanomedicine: promises and challenges for the future of public health
por: Michelle Pautler, et al.
Publicado: (2010)

Nanomedicine applications in orthopedic medicine: state of the art
por: Mazaheri M, et al.
Publicado: (2015)

Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
por: Ranganathan R, et al.
Publicado: (2012)

Nanomedicine in pulmonary delivery
por: Heidi M Mansour, et al.
Publicado: (2009)

Nanomedicine for the reduction of the thrombogenicity of stent coatings
por: Varvara C Karagkiozaki, et al.
Publicado: (2010)

Nanomedicine in cerebral palsy
por: Balakrishnan B, et al.
Publicado: (2013)

Biodegradable Nanopolymers in Cardiac Tissue Engineering: From Concept Towards Nanomedicine
por: Mohammadi Nasr S, et al.
Publicado: (2020)

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa
por: Liu CH, et al.
Publicado: (2014)

Clinical significance of metallothioneins in cell therapy and nanomedicine
por: Sharma S, et al.
Publicado: (2013)

Viruses as nanomedicine for cancer
por: Badrinath N, et al.
Publicado: (2016)

Inhaled chemotherapy in lung cancer: future concept of nanomedicine
por: Zarogoulidis P, et al.
Publicado: (2012)

Nanoparticles for multimodal in vivo imaging in nanomedicine
por: Key J, et al.
Publicado: (2014)

Current applications of graphene oxide in nanomedicine
por: Wu SY, et al.
Publicado: (2015)

Nanoinformatics: a new area of research in nanomedicine
por: Maojo V, et al.
Publicado: (2012)

Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
por: Natarajan JV, et al.
Publicado: (2012)

Nanomedicine as an emerging approach against intracellular pathogens
por: Armstead AL, et al.
Publicado: (2011)

Personalized nanomedicine: future medicine for cancer treatment
por: Shiekh FA
Publicado: (2013)

Regenerative nanomedicine: current perspectives and future directions
por: Chaudhury K, et al.
Publicado: (2014)

Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA
por: Shao Z, et al.
Publicado: (2015)

Research highlights from the International Journal of Nanomedicine 2014
por: Mian SH, et al.
Publicado: (2015)

The eminent need for an academic program in universities to teach nanomedicine
por: V&eacute;lez JM, et al.
Publicado: (2011)

Cancer stem cell theory: therapeutic implications for nanomedicine
por: Wang K, et al.
Publicado: (2013)

Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine
por: Elnaggar YS
Publicado: (2015)

Natural product-based nanomedicine: recent advances and issues
por: Watkins R, et al.
Publicado: (2015)

Nanomedicine strategies for treatment of secondary spinal cord injury
por: White-Schenk D, et al.
Publicado: (2015)

Essential components of a successful doctoral program in nanomedicine
por: van de Ven AL, et al.
Publicado: (2014)

Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases
por: Cosco D, et al.
Publicado: (2012)

Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
por: Han Y, et al.
Publicado: (2014)

Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells
por: Yang S, et al.
Publicado: (2013)

Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
por: Nehoff H, et al.
Publicado: (2014)

Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems
por: Jiang Z, et al.
Publicado: (2012)

Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications
por: Correard F, et al.
Publicado: (2014)

Recent insights on nanomedicine for augmented infection control
por: Singh S, et al.
Publicado: (2019)

Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization techniques
por: Khorasani AA, et al.
Publicado: (2014)

Chemical modulation of M13 bacteriophage and its functional opportunities for nanomedicine
por: Chung WJ, et al.
Publicado: (2014)

In vitro evaluation of anticancer nanomedicines based on doxorubicin and amphiphilic Y-shaped copolymers
por: Li D, et al.
Publicado: (2012)

Biomedical photoacoustics: fundamentals, instrumentation and perspectives on nanomedicine
por: Zou C, et al.
Publicado: (2016)

Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine
por: Xie M, et al.
Publicado: (2013)

Improving intranasal delivery of neurological nanomedicine to the olfactory region using magnetophoretic guidance of microsphere carriers
por: Xi J, et al.
Publicado: (2015)

Catalytic nanomedicine technology: copper complexes loaded on titania nanomaterials as cytotoxic agents of cancer cell
por: Lopez T, et al.
Publicado: (2013)